BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21418619)

  • 21. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved lentiviral transduction of ALS motoneurons in vivo via dual targeting.
    O'Leary VB; Ovsepian SV; Bodeker M; Dolly JO
    Mol Pharm; 2013 Nov; 10(11):4195-206. PubMed ID: 24066863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cromolyn sodium delays disease onset and is neuroprotective in the SOD1
    Granucci EJ; Griciuc A; Mueller KA; Mills AN; Le H; Dios AM; McGinty D; Pereira J; Elmaleh D; Berry JD; Paganoni S; Cudkowicz ME; Tanzi RE; Sadri-Vakili G
    Sci Rep; 2019 Nov; 9(1):17728. PubMed ID: 31776380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
    Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
    Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compensatory changes in degenerating spinal motoneurons sustain functional sparing in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Giusto E; Codrich M; de Leo G; Francardo V; Coradazzi M; Parenti R; Gulisano M; Vicario N; Gulino R; Leanza G
    J Comp Neurol; 2020 Feb; 528(2):231-243. PubMed ID: 31364764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The retrograde delivery of adenovirus vector carrying the gene for brain-derived neurotrophic factor protects neurons and oligodendrocytes from apoptosis in the chronically compressed spinal cord of twy/twy mice.
    Uchida K; Nakajima H; Hirai T; Yayama T; Chen K; Guerrero AR; Johnson WE; Baba H
    Spine (Phila Pa 1976); 2012 Dec; 37(26):2125-35. PubMed ID: 22648027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of Impaired BDNF Signaling, Their Coupled Downstream Serine-Threonine Kinases and SNARE/SM Complex in the Neuromuscular Junction of the Amyotrophic Lateral Sclerosis Model SOD1-G93A Mice.
    Just-Borràs L; Hurtado E; Cilleros-Mañé V; Biondi O; Charbonnier F; Tomàs M; Garcia N; Lanuza MA; Tomàs J
    Mol Neurobiol; 2019 Oct; 56(10):6856-6872. PubMed ID: 30929165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron Disease.
    Herrando-Grabulosa M; Casas C; Talbot K; Aguilera J
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33096857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Feng HL; Leng Y; Ma CH; Zhang J; Ren M; Chuang DM
    Neuroscience; 2008 Aug; 155(3):567-72. PubMed ID: 18640245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. R13 preserves motor performance in SOD1
    Li X; Chen C; Zhan X; Li B; Zhang Z; Li S; Xie Y; Song X; Shen Y; Liu J; Liu P; Liu GP; Yang X
    Theranostics; 2021; 11(15):7294-7307. PubMed ID: 34158851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic administration of scAAV9-IGF1 extends survival in SOD1
    Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
    Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological analysis of a murine model of motoneuron disease.
    Mancuso R; Santos-Nogueira E; Osta R; Navarro X
    Clin Neurophysiol; 2011 Aug; 122(8):1660-70. PubMed ID: 21354365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.
    Glajch KE; Ferraiuolo L; Mueller KA; Stopford MJ; Prabhkar V; Gravanis A; Shaw PJ; Sadri-Vakili G
    PLoS One; 2016; 11(10):e0164103. PubMed ID: 27716798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G⁹³A ALS mice: overlapping effects or limited therapeutic opportunity?
    Mancuso R; Del Valle J; Morell M; Pallás M; Osta R; Navarro X
    Orphanet J Rare Dis; 2014 May; 9():78. PubMed ID: 24885036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
    Leyton-Jaimes MF; Kahn J; Israelson A
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis.
    Feng XH; Yuan W; Peng Y; Liu MS; Cui LY
    Chin Med J (Engl); 2012 May; 125(10):1760-6. PubMed ID: 22800896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS.
    Pasquarelli N; Engelskirchen M; Hanselmann J; Endres S; Porazik C; Bayer H; Buck E; Karsak M; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2017 Sep; 124():157-169. PubMed ID: 28373073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1
    Weerasekera A; Sima DM; Dresselaers T; Van Huffel S; Van Damme P; Himmelreich U
    Neuroimage Clin; 2018; 20():1092-1105. PubMed ID: 30368196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.